DexCom DXCM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.19B-5.4% | $1.26B+4.2% | $1.21B+4.5% | $1.16B+11.7% | $1.04B-7.0% | ||
| $441.6M-5.4% | $466.9M-2.3% | $477.9M+2.0% | $468.3M+4.8% | $447M-2.3% | ||
| $750.3M-5.3% | $792.7M+8.4% | $731.4M+6.2% | $688.8M+16.9% | $589M-10.2% | ||
| 62.9%0.0pp | 62.9%+2.5pp | 60.5%+1.0pp | 59.5%+2.7pp | 56.9%-2.0pp | ||
| $145.3M-2.0% | $148.2M-5.9% | $157.5M+6.3% | $148.2M+2.1% | $145.2M+4.1% | ||
| $349.7M+8.8% | $321.5M-3.0% | $331.4M+1.0% | $328M+5.8% | $310.1M-5.3% | ||
| $495M+5.4% | $469.7M-3.9% | $488.9M+2.7% | $476.2M+4.6% | $455.3M-2.5% | ||
| $255.3M-21.0% | $323M+33.2% | $242.5M+14.1% | $212.6M+59.0% | $133.7M-29.2% | ||
| 21.4%-4.2pp | 25.6%+5.6pp | 20.1%+1.7pp | 18.4%+5.5pp | 12.9%-4.1pp | ||
| $14.2M-19.8% | $17.7M-83.9% | $109.8M+285% | $28.5M+38.3% | $20.6M-8.0% | ||
| $269.5M-20.9% | $340.7M-3.3% | $352.3M+46.1% | $241.1M+56.3% | $154.3M-27.0% | ||
| $70M-4.6% | $73.4M+7.2% | $68.5M+11.7% | $61.3M+25.4% | $48.9M-18.0% | ||
| $199.5M-25.4% | $267.3M-5.8% | $283.8M+57.8% | $179.8M+70.6% | $105.4M-30.5% | ||
| 16.7%-4.5pp | 21.2%-2.2pp | 23.5%+7.9pp | 15.5%+5.4pp | 10.2%-3.4pp | ||
| $0.51-23.9% | $0.67-4.3% | $0.70+55.6% | $0.45+66.7% | $0.27-28.9% | ||
| $322.4M-17.0% | $388.2M+26.8% | $306.1M+11.1% | $275.6M+42.3% | $193.7M-21.5% | ||
| 27%-3.8pp | 30.8%+5.5pp | 25.3%+1.5pp | 23.8%+5.1pp | 18.7%-3.5pp | ||
| $255.3M-21.0% | $323M+33.2% | $242.5M+14.1% | $212.6M+59.0% | $133.7M-29.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is DexCom's revenue?
- DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.
- Is DexCom profitable?
- DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.
- What are DexCom's profit margins?
- Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.
- What is DexCom's earnings per share?
- DexCom's diluted EPS over the trailing twelve months is $2.33.
- Where does DexCom's income statement data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
